- Report
- June 2023
- 326 Pages
China
From €3867EUR$4,000USD£3,322GBP
- Report
- June 2023
- 187 Pages
China
From €1740EUR$1,800USD£1,495GBP
- Report
- July 2021
- 133 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- January 2024
- 96 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- February 2020
- 40 Pages
United States
From €2509EUR$2,595USD£2,155GBP
- Report
- February 2020
- 40 Pages
Russia
From €2509EUR$2,595USD£2,155GBP
- Report
- February 2020
- 40 Pages
Japan
From €2509EUR$2,595USD£2,155GBP
- Report
- February 2020
- 40 Pages
Ireland
From €2509EUR$2,595USD£2,155GBP
- Report
- February 2020
- 40 Pages
Germany
From €2509EUR$2,595USD£2,155GBP
- Report
- February 2020
- 40 Pages
France
From €2509EUR$2,595USD£2,155GBP
- Report
- February 2020
- 40 Pages
China
From €2509EUR$2,595USD£2,155GBP
- Report
- February 2020
- 40 Pages
Brazil
From €2509EUR$2,595USD£2,155GBP
- Report
- February 2020
- 80 Pages
Africa
From €3669EUR$3,795USD£3,151GBP
- Report
- February 2024
- 172 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- February 2022
- 165 Pages
Global
From €5963EUR$6,168USD£5,122GBP
- Report
- April 2019
- 119 Pages
Global
From €5192EUR$5,370USD£4,459GBP
The BCG Vaccine is a vaccine used to protect against tuberculosis (TB). It is the only vaccine available for TB prevention and is used in many countries around the world. The BCG Vaccine market is a subset of the larger Vaccines market, which includes a wide range of vaccines used to prevent and treat various diseases. The BCG Vaccine market is largely driven by the prevalence of TB in different countries, as well as the availability of the vaccine.
The BCG Vaccine market is highly competitive, with many companies offering the vaccine. Some of the major players in the market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Serum Institute of India. Other companies in the market include Emergent BioSolutions, Bavarian Nordic, and Valneva. Show Less Read more
